Concepedia

David M. Kern

DM

66

Publications

2.8K

Citations

30

H-Index

1949

Active since

Affiliations

Janssen (United States)(Current)

Wilmington University

AstraZeneca (United States)

Columbia University

Johnson & Johnson (United States)

David M. Kern is an author at Janssen (United States) specializing in medicine, engineering, and analytical chemistry.

ORCID

Top concepts

Publications per year

1949–2023

66

Publications

66

T Cell Activation and Senescence Predict Subclinical Carotid Artery Disease in HIV-Infected Women

Robert C. Kaplan, Elizabeth Sinclair, Alan Landay et al. · The Journal of Infectious Diseases · 2011 · 284 citations · Full text

Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8

Lauren M. Ellman, Raymond F. Deicken, Sophia Vinogradov et al. · Schizophrenia Research · 2010 · 230 citations · Full text

, , +15

Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns—NHANES 2007–2012

Bingcao Wu, Kelly Bell, Amy H. Stanford et al. · BMJ Open Diabetes Research & Care · 2016 · 210 citations · Full text

Prenatal Exposure to Maternal Infection and Executive Dysfunction in Adult Schizophrenia

Alan S. Brown, Sophia Vinogradov, William S. Kremen et al. · American Journal of Psychiatry · 2009 · 172 citations · Full text

The Potential of the Uranium (V), Uranium (VI) Couple and the Kinetics of Uranium (V) Disproportionation in Perchlorate Media

David M. Kern, E. F. Orlemann · Journal of the American Chemical Society · 1949 · 144 citations

, , +16

Rows per page

1–5 of 66